BridgeMD
New treatment option for Autoimmunity, Inflammation
Official title Secukinumab Open Label Roll-over Extension Protocol
ClinicalTrials.gov ID: NCT04638647
What this study is testing
What is Secukinumab s.c. injection?
Secukinumab s.c. injection is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for autoimmunity, inflammation.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment with secukinumab, and are unable to obtain the marketed secukinumab formulation.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 100
You may be able to join if
- Signed informed consent must be obtained for adult participants before any assessment is performed. Written informed assent and parental permission...
- Ability to communicate effectively with the investigator, to understand and willing to comply with the requirements of the study.
- Participant has completed treatment per protocol in a Novartis study of secukinumab (unless otherwise specified in a parent study protocol)...
- Participant is deriving benefit from secukinumab, investigator believes he/she would continue to derive benefit from secukinumab and the benefit...
- Participant is unable to obtain access to the marketed secukinumab formulation per local prescription and/or reimbursement guidelines.
You likely can't join if
- Participant has prematurely discontinued study treatment in the parent protocol.
- Women of childbearing potential, defined as all women physiologically capable of becoming pregnant, unless they are using methods of contraception...
The study team makes the final eligibility decision.
Where it's taking place
- Fullerton, California, United States
- La Mesa, California, United States
- San Leandro, California, United States
- Santa Monica, California, United States
- Upland, California, United States
- Van Nuys, California, United States
- West Hills, California, United States
- Denver, Colorado, United States
- Boca Raton, Florida, United States
- Homestead, Florida, United States
- Plantation, Florida, United States
- Winter Park, Florida, United States
- Zephyrhills, Florida, United States
- Willowbrook, Illinois, United States
- Indianapolis, Indiana, United States
- Hagerstown, Maryland, United States
- Grand Blanc, Michigan, United States
- Lincoln, Nebraska, United States
- Voorhees Township, New Jersey, United States
- Potsdam, New York, United States
+ 111 more site(s).
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 100 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Fullerton, California, United States; La Mesa, California, United States; San Leandro, California, United States; Santa Monica, California, United States; Upland, California, United States; Van Nuys, California, United States and 125 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.